Evaluation of a Revised Indication for Determining Adult Cochlear Implant Candidacy



Status:Completed
Conditions:Other Indications
Therapuetic Areas:Other
Healthy:No
Age Range:18 - Any
Updated:10/19/2013
Start Date:May 2012
End Date:September 2015
Contact:Kathryn Henion
Email:khenion@cochlear.com
Phone:19723853471

Use our guide to learn which trials are right for you!


The Sponsor values the progression of hearing healthcare practice and acknowledges a need
for re-evaluation of indications for determining adult cochlear implant candidacy. This need
arises from current research, peer reviewed literature, and technological advancement with
concomitant performance outcomes. To address this specifically, the Sponsor proposes to
evaluate the safety and efficacy of the Cochlear™ Nucleus® implant system with a revised
indication.


Existing research, as discussed, supports the opinion that current candidacy criteria are
set conservatively. The Sponsor, in addition to the support of recent peer reviewed
literature illustrating a need for an appropriate criteria and more suitable speech
recognition measure, believe it is appropriate at this time to re-evaluate the candidacy
requirements associated with adult cochlear implantation. Specifically, this will be
accomplished by evaluating the safety and efficacy of the Cochlear™ Nucleus® cochlear
implant system under revised cochlear implant indications. The proposed approach would be to
evaluate individuals scoring between 10 - 40% inclusively on monosyllabic words (CNC) who do
not meet current approved speech perception criteria with the widely used sentence measure
HINT in quiet. No change to current qualifying audiometric criteria (bilateral moderate to
profound sensorineural hearing loss in the low frequencies and profound hearing loss in the
mid to high speech frequencies) for implant candidacy is proposed.

Inclusion Criteria:

- Eighteen years of age or older at the time of the study.

- Preoperative aided CNC word score in quiet of greater than or equal to 10% and less
than or equal to ¬¬40% in the ear to be implanted; equal to but no better than 50% in
the contralateral ear

- Bilateral moderate to profound hearing loss in the low frequencies (up to 1000 Hz)
and profound sensorineural hearing loss in the high speech frequencies (3000 Hz and
above)

- Willingness to use bimodal stimulation (i.e. a cochlear implant on one ear and a
hearing aid on the contralateral ear) through at least 6-months postactivation.

- English spoken as the primary language.

Exclusion Criteria:

- Congenital hearing loss (for the purpose of this study, onset prior to 2
years-of-age).

- Preoperative aided HINT sentence score less than or equal to 50% in the ear to be
implanted

- Ossification, absence of cochlear development or any other cochlear anomaly that
might prevent complete insertion of the electrode array.

- Hearing loss of neural or central origin (e.g., deafness due to lesions on the
acoustic nerve or central auditory pathway).

- Active middle-ear infection.

- Unwillingness and/or inability of the candidate to comply with all investigational
requirements including, but not limited to, study protocol and surgical procedure.
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials